메뉴 건너뛰기




Volumn 20, Issue 23, 2002, Pages 4567-4573

Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN ANTAGONIST; PROSTATE SPECIFIC ANTIGEN;

EID: 0036895121     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.03.061     Document Type: Article
Times cited : (238)

References (25)
  • 1
    • 0011802140 scopus 로고    scopus 로고
    • Biochemical (PSA): Recurrence probability following radical retropubic prostatectomy for clinically localized prostate cancer
    • abstr 610
    • Han M, Lai S, Partin AW, et al: Biochemical (PSA): Recurrence probability following radical retropubic prostatectomy for clinically localized prostate cancer. J Urol 165:149, 2001 (abstr 610)
    • (2001) J Urol , vol.165 , pp. 149
    • Han, M.1    Lai, S.2    Partin, A.W.3
  • 2
    • 0033526343 scopus 로고    scopus 로고
    • Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis
    • Shipley WU, Thames HD, Sandler HM, et al: Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis. JAMA 281:1598-1604, 1999
    • (1999) JAMA , vol.281 , pp. 1598-1604
    • Shipley, W.U.1    Thames, H.D.2    Sandler, H.M.3
  • 3
    • 0032538069 scopus 로고    scopus 로고
    • Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    • D'Amico AV, Whittington R, Malkowicz SB, et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969-974, 1998
    • (1998) JAMA , vol.280 , pp. 969-974
    • D'Amico, A.V.1    Whittington, R.2    Malkowicz, S.B.3
  • 4
    • 0032550753 scopus 로고    scopus 로고
    • A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
    • Kattan MW, Easthan JA, Stapleton AMF, et al: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90:766-771, 1998
    • (1998) J Natl Cancer Inst , vol.90 , pp. 766-771
    • Kattan, M.W.1    Easthan, J.A.2    Stapleton, A.M.F.3
  • 5
    • 0032537993 scopus 로고    scopus 로고
    • Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
    • Albertsen PC, Hanley JA, Gleason DF, et al: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975-980, 1998
    • (1998) JAMA , vol.280 , pp. 975-980
    • Albertsen, P.C.1    Hanley, J.A.2    Gleason, D.F.3
  • 6
    • 0033526309 scopus 로고    scopus 로고
    • Natural history of progression after PSA elevation following radical prostatectomy
    • Pound CR, Partin AW, Eisenberger MA, et al: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591-1597, 1999
    • (1999) JAMA , vol.281 , pp. 1591-1597
    • Pound, C.R.1    Partin, A.W.2    Eisenberger, M.A.3
  • 7
    • 0031014008 scopus 로고    scopus 로고
    • Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations
    • Lee WR, Hanks GE, Hanlon A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations. J Clin Oncol 15:230-238, 1997
    • (1997) J Clin Oncol , vol.15 , pp. 230-238
    • Lee, W.R.1    Hanks, G.E.2    Hanlon, A.3
  • 8
    • 0001916430 scopus 로고
    • Histologic grading and staging of prostatic carcinoma
    • Philadelphia, PA, Lea & Febiger
    • Gleason DF and the Veterans Administration Cooperative Urological Research Group: Histologic grading and staging of prostatic carcinoma, in Tannenbaum M (ed): Urologic Pathology. Philadelphia, PA, Lea & Febiger, 1977, pp 171-187
    • (1977) Urologic Pathology , pp. 171-187
    • Gleason, D.F.1
  • 9
    • 0030887860 scopus 로고    scopus 로고
    • Using prostate-specific antigen to eliminate the staging radionuclide bone scan
    • Lee CT, Oesterling JE: Using prostate-specific antigen to eliminate the staging radionuclide bone scan. Urol Clin North Am 24:389-394, 1997
    • (1997) Urol Clin North Am , vol.24 , pp. 389-394
    • Lee, C.T.1    Oesterling, J.E.2
  • 11
    • 0033026308 scopus 로고    scopus 로고
    • Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial
    • Dearnaley D, Khoo V, Norman A, et al: Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial. Lancet 353:267-272, 1999
    • (1999) Lancet , vol.353 , pp. 267-272
    • Dearnaley, D.1    Khoo, V.2    Norman, A.3
  • 12
    • 0030906817 scopus 로고    scopus 로고
    • Consensus statement: Guidelines for PSA following radiation therapy
    • Cox JD, for the American Society for Therapeutic Radiology and Oncology Consensus Panel: Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997
    • (1997) Int J Radiat Oncol Biol Phys , vol.37 , pp. 1035-1041
    • Cox, J.D.1
  • 13
    • 0002595781 scopus 로고
    • Simultaneous inferences and other topic in regression analysis-1
    • Homewood, IL, Richard D. Irwin, Inc
    • Neter J, Wasserman W, Kutner M (eds): Simultaneous inferences and other topic in regression analysis-1, in Applied Linear Regression Models. Homewood, IL, Richard D. Irwin, Inc, 1983, pp 150-153
    • (1983) Applied Linear Regression Models , pp. 150-153
    • Neter, J.1    Wasserman, W.2    Kutner, M.3
  • 14
    • 0034307224 scopus 로고    scopus 로고
    • Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy
    • Sandler HM, Dunn RL, McLaughlin PW, et al: Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. Int J Radiat Oncol Biol Phys 48:629-633, 2000
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , pp. 629-633
    • Sandler, H.M.1    Dunn, R.L.2    McLaughlin, P.W.3
  • 15
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 16
    • 21144484803 scopus 로고
    • On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data
    • Gaynor JJ, Feur FJ, Tan CC, et al: On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Am Stat Assoc 88:400-409, 1993
    • (1993) J Am Stat Assoc , vol.88 , pp. 400-409
    • Gaynor, J.J.1    Feur, F.J.2    Tan, C.C.3
  • 17
    • 0032950295 scopus 로고    scopus 로고
    • Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
    • Kattan MW, Wheeler TM, Scardino PT: Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17:1499-1507, 1999
    • (1999) J Clin Oncol , vol.17 , pp. 1499-1507
    • Kattan, M.W.1    Wheeler, T.M.2    Scardino, P.T.3
  • 18
    • 0034666335 scopus 로고    scopus 로고
    • Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant therapy trials
    • D'Amico AV, Whittington R, Malkowicz SB, et al: Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant therapy trials. J Clin Oncol 18:3240-3246, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 3240-3246
    • D'Amico, A.V.1    Whittington, R.2    Malkowicz, S.B.3
  • 19
    • 0030856678 scopus 로고    scopus 로고
    • Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
    • Bolla M, Gonsalez D, Warde P, et al: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295-300, 1997
    • (1997) N Engl J Med , vol.337 , pp. 295-300
    • Bolla, M.1    Gonsalez, D.2    Warde, P.3
  • 20
    • 0030815150 scopus 로고    scopus 로고
    • Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen
    • Patel A, Dorey F, Franklin J, et al: Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol 158:1441-1445, 1997
    • (1997) J Urol , vol.158 , pp. 1441-1445
    • Patel, A.1    Dorey, F.2    Franklin, J.3
  • 21
    • 0035003725 scopus 로고    scopus 로고
    • PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer
    • Roberts SG, Blute ML, Bergstralh EJ, et al: PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 76:576-581, 2001
    • (2001) Mayo Clin Proc , vol.76 , pp. 576-581
    • Roberts, S.G.1    Blute, M.L.2    Bergstralh, E.J.3
  • 22
    • 0030857412 scopus 로고    scopus 로고
    • Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy
    • Sartor CI, Strawderman MH, Lin XH, et al: Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy. Int J Radiat Oncol Biol Phys 38:941-947, 1997
    • (1997) Int J Radiat Oncol Biol Phys , vol.38 , pp. 941-947
    • Sartor, C.I.1    Strawderman, M.H.2    Lin, X.H.3
  • 23
    • 0031403675 scopus 로고    scopus 로고
    • Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial - The Medical Research Council Prostate Cancer Working Party Investigators Group
    • Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial - The Medical Research Council Prostate Cancer Working Party Investigators Group. Br J Urol 79:235-246, 1997
    • (1997) Br J Urol , vol.79 , pp. 235-246
  • 24
    • 0033540004 scopus 로고    scopus 로고
    • Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
    • Messing EM, Manola J, Sarosdy M, et al: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341:1781-1788, 1999
    • (1999) N Engl J Med , vol.341 , pp. 1781-1788
    • Messing, E.M.1    Manola, J.2    Sarosdy, M.3
  • 25
    • 0024520844 scopus 로고
    • Surrogate endpoints in clinical trials: Definition and operational criteria
    • Prentice RL: Surrogate endpoints in clinical trials: Definition and operational criteria. Stat Med 8:431-440, 1989
    • (1989) Stat Med , vol.8 , pp. 431-440
    • Prentice, R.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.